Sriram Ryali Insider Trading $EIGR Eiger BioPharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sriram Ryali.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sriram Ryali. Sriram Ryali is Chief Financial Officer in Eiger BioPharmaceuticals, Inc. ($EIGR).
Sriram Ryali in Eiger BioPharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Sriram Ryali: Chief Financial Officer
Holdings: 18,152 shares
Current Value: $210,563
Latest Transaction: May 11 2021
$EIGR Market Capitalization: $93.59M
$EIGR Previous Close: $11.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Sriram Ryali in Eiger BioPharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 2021 | EIGR | Eiger BioPharmaceu ... | Ryali Sriram | Chief Financial Off ... | Option Exercise | A | 8.49 | 87,000 | 738,630 | 87,000 | |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Ryali Sriram | Chief Financial Off ... | Option Exercise | A | 9.99 | 97,500 | 974,025 | 97,500 | |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Ryali Sriram | Chief Financial Off ... | Grant | A | 0.00 | 16,250 | 0 | 18,152 | 1.9 K to 18.2 K (+854.36 %) |
| Mar 13 2020 | EIGR | Eiger BioPharmaceu ... | Ryali Sriram | Chief Financial Off ... | Option Exercise | A | 5.60 | 65,000 | 364,000 | 65,000 | |
| Mar 13 2020 | EIGR | Eiger BioPharmaceu ... | Ryali Sriram | Chief Financial Off ... | Grant | A | 7.31 | 229 | 1,674 | 1,628 | 1.4 K to 1.6 K (+16.37 %) |
| Sep 06 2019 | EIGR | Eiger BioPharmaceu ... | Ryali Sriram | Chief Financial Off ... | Grant | A | 9.37 | 149 | 1,396 | 1,399 | 1.3 K to 1.4 K (+11.92 %) |
| Apr 22 2019 | EIGR | Eiger BioPharmaceu ... | Ryali Sriram | Chief Financial Off ... | Buy | P | 11.08 | 1,250 | 13,853 | 1,250 | 0 to 1.3 K |
| Apr 22 2019 | EIGR | Eiger BioPharmaceu ... | Ryali Sriram | Chief Financial Off ... | Buy | P | 11.08 | 1,250 | 13,853 | 1,250 | 0 to 1.3 K |
| Jan 04 2019 | EIGR | Eiger BioPharmaceu ... | Ryali Sriram | Chief Financial Off ... | Option Exercise | A | 10.46 | 90,000 | 941,400 | 90,000 |
Page: 1